We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

295 hedge funds and large institutions have $653M invested in ARK Genomic Revolution ETF in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 80 increasing their positions, 94 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

7.05% more ownership

Funds ownership: 27.45% → 34.5% (+7.1%)

8% less funds holding

Funds holding: 319 → 295 (-24)

13% less capital invested

Capital invested by funds: $750M → $653M (-$96.7M)

15% less repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 94

35% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 46

47% less call options, than puts

Call options by funds: $51.8M | Put options by funds: $97.2M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
295
Holders Change
-24
Holders Change %
-7.52%
% of All Funds
4.7%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
80
Reduced
94
Closed
46
Calls
$51.8M
Puts
$97.2M
Net Calls
-$45.5M
Net Calls Change
-$45.6M

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$39.7M
2
Citigroup
Citigroup
New York
+$33.9M
3
Bank of America
Bank of America
North Carolina
+$28.5M
4
Morgan Stanley
Morgan Stanley
New York
+$17.4M
5
Goldman Sachs
Goldman Sachs
New York
+$7.39M

Top Sellers

Rank Fund Capital Flow
1
AWA
Arete Wealth Advisors
Illinois
-$227M
2
Chevy Chase Trust
Chevy Chase Trust
Maryland
-$3.45M
3
Jane Street
Jane Street
New York
-$3.26M
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$2.67M
5
TRCT
Tower Research Capital (TRC)
New York
-$2.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
276
WealthPLAN Partners
Nebraska
$932 +$961 +31 New
BWP
277
Baldwin Wealth Partners
Massachusetts
$902 – – –
FWM
278
Focused Wealth Management
New York
$902 +$930 +30 New
WWP
279
WR Wealth Planners
Missouri
$902 +$930 +30 New
WBC
280
West Branch Capital
Massachusetts
$854 – – –
BC
281
Barrett & Company
Rhode Island
$752 – – –
AWM
282
Activest Wealth Management
Florida
$717 -$50.6K -1,633 -98%
FA
283
Financial Avengers
California
$692 – – –
NSG
284
Nalls Sherbakoff Group
Tennessee
$660 +$713 +23 New
EWA
285
EverSource Wealth Advisors
Alabama
$601 -$1.24K -40 -67%
JWM
286
Janiczek Wealth Management
Colorado
$522 – – –
EWM
287
Evermay Wealth Management
Virginia
$452 -$62 -2 -12%
CBT
288
Central Bank & Trust
Kentucky
$450 – – –
AAG
289
Armstrong Advisory Group
Massachusetts
$391 – – –
OIA
290
Optimum Investment Advisors
Illinois
$303 – – –
NC
291
NewSquare Capital
Pennsylvania
$301 – – –
YAL
292
Your Advocates Ltd
Texas
$301 – – –
SJIM
293
St. Johns Investment Management
Florida
$120 – – –
Fidelity Investments
294
Fidelity Investments
Massachusetts
$90 -$155 -5 -63%
BBHC
295
Brown Brothers Harriman & Co
New York
$60 – – –
Chevy Chase Trust
296
Chevy Chase Trust
Maryland
– -$3.45M -122,216 Closed
Millennium Management
297
Millennium Management
New York
– -$2.03M -65,630 Closed
CCM
298
Consolidated Capital Management
California
– -$1.8M -63,610 Closed
PFO
299
Pathstone Family Office
New Jersey
– -$1.19M -32,114 Closed
CCM
300
Canal Capital Management
Virginia
– -$744K -26,352 Closed
10 11
12
13 14

ARKG Hedge Fund Activity: Q1 2023 in Review

295 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2023, worth a combined $653M — down 13% from $750M a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of ARKG and 30 opened new positions — a net loss of 16 holders — while 94 trimmed existing stakes and 80 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $39.7M. The largest seller was Arete Wealth Advisors, exiting entirely with an estimated $227M sold.

  • 295 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2023, down from 319 in Q4 2022.
  • Funds reported $653M of ARK Genomic Revolution ETF stock for Q1 2023, down 13% quarter-over-quarter.
  • 30 funds opened new ARK Genomic Revolution ETF positions in Q1 2023 and 46 closed out, a net change of -16 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2023 was BNP Paribas Financial Markets, an estimated $39.7M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2023 was Arete Wealth Advisors, an estimated $227M sold.

Based on aggregated 13F filings for Q1 2023.